Pharmacologic receptor activity of rabbit aorta. Effect of dithiothreitol and N-ethylmaleimide.
D006631:Amine Oxidase (Copper-Containing) / Q000378:metabolism; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000201:enzymology / Q000502:physiology*; D003545:Cysteine / Q000494:pharmacology; D003553:Cystine / Q000494:pharmacology; D004229:Dithiothreitol / Q000494:pharmacology*; D004896:Erythritol / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology*; D006632:Histamine / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D008780:Methyltransferases / Q000378:metabolism; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000502:physiology*; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011189:Potassium Chloride / Q000494:pharmacology; D011817:Rabbits; D011955:Receptors, Drug / Q000187:drug effects*; D012701:Serotonin / Q000494:pharmacology
D011955:Receptors, Drug; D000804:Angiotensin II; D012701:Serotonin; D003553:Cystine; D011189:Potassium Chloride; D006632:Histamine; D006631:Amine Oxidase (Copper-Containing); D008780:Methyltransferases; D003545:Cysteine; D005033:Ethylmaleimide; D004896:Erythritol; D004229:Dithiothreitol; D009638:Norepinephrine; D010646:Phentolamine